Lung cancer is the leading cause of cancer death in the United States, accounting for more deaths annually than colorectal, breast, and prostate cancers combined. Approximately 70% of cases occur in adults 65 and older, and cigarette smoking drives 85 to 90% of diagnoses. The screening picture is stark: only 14 to 18% of eligible adults were up to date with low-dose CT screening in 2022 — the largest gap in U.S. cancer screening quality. The tools to catch this cancer early exist. Most eligible patients have never used them.
AAVBC's Lung Cancer Quick Reference Guide equips primary care clinicians with a practical reference for closing that gap and managing lung cancer across the care continuum. It covers LDCT screening eligibility, shared decision-making visit requirements, ICD-10 subsite and laterality coding, histologic subtype documentation, biomarker testing, smoking cessation, comorbidity management, and MEAT documentation standards.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of lung cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Lung cancer is the leading cause of cancer death in the United States, accounting for more deaths annually than colorectal, breast, and prostate cancers combined. Approximately 70% of cases occur in adults 65 and older, and cigarette smoking drives 85 to 90% of diagnoses. The screening picture is stark: only 14 to 18% of eligible adults were up to date with low-dose CT screening in 2022 — the largest gap in U.S. cancer screening quality. The tools to catch this cancer early exist. Most eligible patients have never used them.
AAVBC's Lung Cancer Quick Reference Guide equips primary care clinicians with a practical reference for closing that gap and managing lung cancer across the care continuum. It covers LDCT screening eligibility, shared decision-making visit requirements, ICD-10 subsite and laterality coding, histologic subtype documentation, biomarker testing, smoking cessation, comorbidity management, and MEAT documentation standards.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of lung cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
